ATS completes acquisition of Avidity Science

ATS Corporation (“ATS”), today announced the successful completion of its acquisition of Avidity Science, LLC ("Avidity"), a growing designer and manufacturer of automated water purification solutions for biomedical and life science applications.

ATS entered into a definitive agreement and announced its intention to acquire Avidity on September 22, 2023.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Avidity Science. (2024, August 28). ATS completes acquisition of Avidity Science. News-Medical. Retrieved on November 28, 2024 from https://www.news-medical.net/news/20240827/ATS-completes-acquisition-of-Avidity-Science.aspx.

  • MLA

    Avidity Science. "ATS completes acquisition of Avidity Science". News-Medical. 28 November 2024. <https://www.news-medical.net/news/20240827/ATS-completes-acquisition-of-Avidity-Science.aspx>.

  • Chicago

    Avidity Science. "ATS completes acquisition of Avidity Science". News-Medical. https://www.news-medical.net/news/20240827/ATS-completes-acquisition-of-Avidity-Science.aspx. (accessed November 28, 2024).

  • Harvard

    Avidity Science. 2024. ATS completes acquisition of Avidity Science. News-Medical, viewed 28 November 2024, https://www.news-medical.net/news/20240827/ATS-completes-acquisition-of-Avidity-Science.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.